Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRolls-Royce Regulatory News (RR.)

Share Price Information for Rolls-Royce (RR.)

Share Price is delayed by 15 minutes
Get Live Data
1,393.60    -18.20 (-1.29%)
Bid:
1,392.80
Ask:
1,393.40
Spread: 0.60 (0.043%)
Market Cap: £115.50b
RR. Live PriceLast checked at - London Stock Exchange

Intraday Rolls-Royce Share Chart

Paris Airshow and Pre-Close Statement

16 Jun 2017 07:00

RNS Number : 2538I
Rolls-Royce Holdings plc
16 June 2017
 

16 June 2017

 

ROLLS-ROYCE HOLDINGS PLC

PARIS AIRSHOW and PRE-CLOSE STATEMENT

 

Rolls-Royce Holdings plc will be meeting investors over the next two weeks, principally at the Paris Airshow, and in advance of the close period ahead of its Half Year Results on 1 August 2017.

Rolls-Royce has started 2017 well, with all businesses performing in line with our expectations. As a result, Group expectations for first half revenue, profit and free cash flow remain unchanged from that provided at the AGM in May.

Looking at the year as a whole, against a backdrop of mixed market conditions, we remain focused on the delivery of our engine production ramp up, the continued execution of our transformation programme and growing our free cash flow. Full year expectations for revenue, profit and free cash flow are unchanged from those outlined in February 2017.

The 2017 outlook excludes the year-on-year effect of foreign exchange translation on our reported results. Our guidance at this stage of the year is unchanged. If rates remain unchanged from those seen recently, the impact of the average year-on-year movement on the translation of our overseas subsidiaries results would improve full year reported revenues by around £400m and improve reported profit before tax by around £50m.

Over the next few days the Company will be holding a number of meetings with investors and analysts; all comments made at these events are expected to be consistent with the outlook reconfirmed above and should not be seen as a change to any of the longer term comments made on the company's growth prospects.

 

Commenting on the performance to date, Warren East, Chief Executive of Rolls-Royce, said: "2017 has started well, although we have a great deal more to do to deliver the full year. As expected, near term cash flow performance remains challenging as we continue to invest in transforming and growing the business to benefit future years."

 

"News updates around events such as the Paris Airshow are increasingly expected to reflect our transition from a period of above-trend order book growth to one of operational delivery. Our ramp up in large engine production is progressing well, reflecting the significant investments in manufacturing capability in recent years. Across the wider group, all our businesses continue to focus on transformation activities and are benefiting from our increased focus on pace and simplicity."

 

 

 

For further information please contact:

 

Investors:

John Dawson +44 7557 287101

Helen Harman +44 7968 906645

Ross Hawley +44 7920 822534

 

Media:

Richard Wray +44 20 7227 9163

 

This announcement contains forward-looking statements. Any statements that express forecasts, expectations and projections are not guarantees of future performance and will not be updated. By their nature, these statements involve risk and uncertainty, and a number of factors could cause material differences to the actual results or developments. This announcement is intended to provide information to shareholders, is not designed to be relied upon by any other party, or for any other purpose and the Company and its directors accept no liability to any other person other than under English law.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGMGMVVKZGNZM
Date   Source Headline
17th Jun 20267:00 amRNSTransaction in Own Shares
12th Jun 202611:00 amRNSDirector/PDMR Shareholding
11th Jun 20263:30 pmRNSDirector/PDMR Shareholding
10th Jun 20265:34 pmRNSTransaction in Own Shares
9th Jun 20264:30 pmRNSDirector/PDMR Shareholding
5th Jun 20263:30 pmRNSDirector/PDMR Shareholding
1st Jun 20263:00 pmRNSTotal Voting Rights
29th May 20263:30 pmRNSDirector/PDMR Shareholding
27th May 20267:00 amRNSTransaction in Own Shares
20th May 20267:00 amRNSTransaction in Own Shares
13th May 20267:00 amRNSTransaction in Own Shares
8th May 20263:00 pmRNSDirector/PDMR Shareholding
6th May 20267:00 amRNSTransaction in Own Shares
1st May 20263:30 pmRNSDirector/PDMR Shareholding
1st May 202610:30 amRNSTotal Voting Rights
30th Apr 20263:00 pmRNSResult of AGM
30th Apr 20267:00 amRNSAGM Statement and Trading Update
29th Apr 20267:00 amRNSTransaction in Own Shares
28th Apr 20262:00 pmRNSDirector/PDMR Shareholding
22nd Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20264:30 pmRNSDirector/PDMR Shareholding
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 202612:00 pmRNSTotal Voting Rights
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 202611:00 amRNSDirector/PDMR Shareholding
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20264:00 pmRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20264:30 pmRNSDirector/PDMR Shareholding
10th Mar 20264:30 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 202611:00 amRNSAnnual Report 2025 and Annual General Meeting 2026

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.